Study Title: A Phase 3 Randomized Study Comparing Talquetamab in Combination With Daratumumab (SC) and Pomalidomide (Tal-DP) or Talquetamab (SC) in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Green, Kimberly, at greekm@musc.edu.Study Coordinator, Schaefer, Matthew, at schaefma@musc.edu.Trial opened at the following institutions: Medical University of South Carolina